abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
11051: Thrombosis Panel (11051X) Print View
Interpretation      
Protein C Activity CLOTTING  70 - 180  % normal 
Protein S Activity CLOT DET  Male: 70 - 150
Female: 60 - 140 
% normal 
Antithrombin III Activity CHROMOGENIC  80 - 120  % normal 
APC Resistance CLOT DET  > 2.0  ratio 

PRIMARY
1 Plasma Citrated 5 (2.5) mL   Frozen - 14 Day(s)  
ALTERNATE

5 mL (2.5) plasma collected in 3.2% sodium citrate (Lt blue-top tube)
`<
Platelet Poor Plasma: Centrifuge light blue-top tube 15 minutes at
approx. 1500 x g within 60 minutes of collection. Using a plastic
pipette, remove plasma, taking care to avoid the WBC/platelet buffy
layer and place into a plastic vial. Centrifuge a second time and
transfer platelet-poor plasma into a new plastic vial. Plasma must
be free of platelets (<10,000/mcl). Freeze immediately and ship on
dry ice. `<
-70 degrees: 6 months
`<
Reject Criteria: Thawed plasma; gross hemolysis
`<
Transport Temperature: Frozen
Setup Schedule
Monday-Saturday

Reported (Analytical Time)
Next day

CPT Codes
85303,85306,85300,85307

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
METHODOLOGY: APTT-Based Assay (Clot-Based), Clotting Assay, Clot Detection, Chromogenic Substrate, RVVT Based Clot Assay






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database